A systematic review of the safety and efficacy on cognitive function of herbal and nutritional medicines in older adults with and without subjective cognitive impairment
Abstract Background Subjective cognitive impairment (SCI) substantially increases dementia risk and is often conceptualised as the preclinical asymptomatic phase of the cognitive decline continuum. Due to the lack of pharmacological interventions available to treat SCI and reduce dementia risk, and...
Main Authors: | Adele E. Cave, Dennis H. Chang, Gerald W. Münch, Genevieve Z. Steiner-Lim |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-08-01
|
Series: | Systematic Reviews |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13643-023-02301-6 |
Similar Items
-
MCI, en dan? De toekomst van 'mild cognitive impairment'
by: Han F.A. Diesfeldt
Published: (2014-11-01) -
Targeted plasma metabolomics reveals potential biomarkers of the elderly with mild cognitive impairment in Qingdao rural area
by: Yuchi Meng, et al.
Published: (2024-12-01) -
Cognitive impairment without dementia: A current view of the problem
by: Yu. A. Starchina
Published: (2017-07-01) -
Event-related potential markers of subjective cognitive decline and mild cognitive impairment during a sustained visuo-attentive task
by: A.A. Vergani, et al.
Published: (2025-01-01) -
Olfactory Identification as a Biomarker for Cognitive Impairment: Insights from Healthy Aging, Subjective Cognitive Decline, and Mild Cognitive Impairment
by: Jaime Bouhaben, et al.
Published: (2024-11-01)